Abstract
Carnitine transporter defect is an autosomal recessive disorder caused by mutations in the SLC22A5 gene that encodes the high-affinity carnitine transporter OCTN2. Affected patients can present with predominant metabolic or cardiac manifestations. Early recognition of this disorder in a context of life-threatening cardiac failure and treatment with carnitine can be lifesaving in this inborn error of fatty acid oxidation. Here we describe a boy with a severe cardiomyopathy and severe anemia who improved with carnitine therapy. Physiopathology of anemia, a probably less recognized symptom of carnitine deficiency, is also discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cemeroglu AP, Kocabas CN, Coskun T, Gurgey A (2001) Low serum carnitine concentrations in healthy children with iron deficiency anemia. Pediatr Hematol Oncol 18:491–495
Evangeliou A, Vlassopoulos D (2003) Carnitine metabolism and deficit—when supplementation is necessary? Curr Pharm Biotechnol 4:211–219
Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibira S, Matsuishi T, Tsuji A (1999) Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet 8:2247–2254
Longo N, Amat di San Filippo C, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 142:77–85
Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91–94
Ogier de Baulny H, Superti-Furga A (2006) Disorders of mitochondrial fatty acid oxidation and ketone body metabolism. In: Blau N, Hoffman GF, Leonard J, Clarke JTR (eds) Physician’s guide to the treatment and follow-up of metabolic disease 2006. Springer, Berlin, Heidelberg, New York, pp 147–160
Stanley CA, Bennett MJ, Mayatepek E (2006) Disorders of fatty acid oxidation and related metabolic pathways. In: Fernandes J, Saudubray JM, van Den Berghe G, Walter JH (eds) Inborn metabolic disease diagnostic and treatment 2006, 4th ed. Springer, Heidelberg, pp 177–188
Tanzer F, Hizel S, Cetinkaya O, Sekreter E (2001) Serum free carnitine and total triglyceride levels in children with iron deficiency anemia. Int J Vitam Nutr Res 71:66–69
Tein I (2003) Carnitine transport: pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis 26:147–169
Tein I, Di Mauro S (1992) Primary systemic carnitine deficiency manifested by carnitine-responsive cardiomyopathy. In: Ferrari R, Di Mauro S, Sherwood G (eds) L-carnitine and its role in medicine: from function to therapy 1992. Academic Press, San Diego, pp 155–183
Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM (1988) Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med 319:1331–1336
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cano, A., Ovaert, C., Vianey-Saban, C. et al. Carnitine Membrane Transporter Deficiency: A Rare Treatable Cause of Cardiomyopathy and Anemia. Pediatr Cardiol 29, 163–165 (2008). https://doi.org/10.1007/s00246-007-9051-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-007-9051-9